Mesa Laboratories Inc (MLAB)
Profitability ratios
Return on sales
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 61.19% | 58.94% | 58.57% | 58.30% | 59.10% | 61.02% | 60.49% | 60.90% | 61.02% | 60.98% | 59.01% | 59.15% | 59.18% | 60.41% | 63.50% | 63.98% | 64.69% | 61.87% | 58.41% | 56.67% |
| Operating profit margin | 6.78% | 7.62% | 5.37% | 3.89% | 1.14% | -4.38% | -2.74% | -0.82% | -2.53% | 1.88% | -0.77% | -0.76% | 3.26% | 5.57% | 8.15% | 8.57% | 8.95% | 6.60% | 4.06% | 4.37% |
| Pretax margin | 2.47% | -113.50% | -116.33% | -121.05% | -127.50% | -0.28% | -0.29% | 1.86% | -0.18% | -0.07% | -1.98% | -1.63% | 1.94% | 5.21% | 3.59% | 2.14% | 1.44% | -2.57% | -2.21% | -1.27% |
| Net profit margin | -0.82% | -104.92% | -107.56% | -111.89% | -117.60% | 0.45% | -0.34% | 0.83% | 0.42% | -0.66% | -1.78% | -0.78% | 1.01% | 4.64% | 3.56% | 2.92% | 2.30% | -1.93% | -2.04% | -1.83% |
Mesa Laboratories Inc's profitability ratios display fluctuations over the reporting periods.
- Gross profit margin has shown mild variation, ranging from 56.67% to 64.69% but has generally remained above 60%, indicating efficient production and pricing strategies.
- Operating profit margin has been more volatile, moving from positive percentages to negative figures, with a peak of 8.95% in March 2021, but dropping to -4.38% in December 2023. The company may have faced challenges managing operating expenses during certain periods.
- Pretax margin fluctuated significantly, with negative figures in several quarters, notably hitting -127.50% in March 2024. However, there were positive margins in other quarters, suggesting variability in the company's ability to generate profits before taxes.
- Net profit margin also demonstrated substantial variability, with negative margins prevalent. The highest negative margin recorded was -117.60% in March 2024, indicating that the company's net profit was significantly impacted in that period.
In conclusion, Mesa Laboratories Inc's profitability has been inconsistent, with varying margins across different periods, implying fluctuations in the company's ability to generate profits at different stages. Further analysis may be required to understand the factors influencing these fluctuations and the company's overall financial performance.
Return on investment
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | — | 4.14% | 2.70% | 1.98% | 0.55% | -1.26% | -0.92% | -0.28% | -0.84% | 0.63% | -0.26% | -0.22% | 0.85% | 1.26% | 1.91% | 1.94% | 2.00% | 1.38% | 0.88% | 0.92% |
| Return on assets (ROA) | — | -57.06% | -54.10% | -56.84% | -56.90% | 0.13% | -0.11% | 0.28% | 0.14% | -0.22% | -0.61% | -0.23% | 0.26% | 1.05% | 0.84% | 0.66% | 0.51% | -0.41% | -0.44% | -0.39% |
| Return on total capital | — | -167.27% | -158.84% | -174.95% | -185.67% | 1.14% | 1.00% | 2.29% | 1.11% | 1.18% | 0.04% | 0.24% | 1.93% | 3.36% | 2.72% | 2.47% | 2.74% | 0.35% | 0.50% | 0.58% |
| Return on equity (ROE) | — | -160.71% | -152.15% | -166.07% | -174.87% | 0.24% | -0.18% | 0.47% | 0.24% | -0.38% | -1.06% | -0.41% | 0.48% | 1.91% | 1.28% | 1.02% | 0.76% | -0.61% | -0.66% | -0.58% |
Profitability ratios provide insight into a company's ability to generate profits relative to its assets, capital, and equity.
1. Operating Return on Assets (Operating ROA): Mesa Laboratories Inc's Operating ROA has fluctuated over the periods provided, reaching a peak of 4.14% on December 31, 2024, but showing negative values in some periods. This ratio indicates the company's operational efficiency in utilizing its assets to generate operating profits.
2. Return on Assets (ROA): ROA also displays fluctuations, with significant negative values in earlier periods, likely indicating challenges in asset utilization and profitability. However, the ratio gradually improves towards positive values, suggesting better asset management and profitability in later periods.
3. Return on Total Capital: Mesa Laboratories Inc's Return on Total Capital shows a similar trend to ROA, with both negative and positive values observed. The ratio indicates the company's ability to generate profits from all capital sources, including debt and equity.
4. Return on Equity (ROE): The ROE ratio reflects Mesa Laboratories Inc's ability to generate profits for its shareholders. Similar to ROA, ROE fluctuates over time, with negative values in some periods but improving towards positive values in later periods.
Overall, Mesa Laboratories Inc's profitability ratios demonstrate variability over time, reflecting different levels of operational efficiency, asset utilization, and profitability. It is essential for investors and analysts to monitor these ratios to assess the company's performance and financial health accurately.